Sign in
CYTO Stock Price, Chart, Stats & News
Altamira Therapeutics Ltd.
Save
Altamira Therapeutics Ltd. (CYTO) does not currently pay a dividend.
1.13M
Market cap
0.16x
Current P/E
–
Forward P/E
CYTO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -84.03% |
ROE | -111.64% |
D/E | 0.05x |
Interest coverage ratio | – |
CYTO valuation
P/E | 0.16x |
P/S | – |
P/B | 0.02x |
P/CF | -0.02x |
P/FCF | -0.18x |
P/OCF | -0.02x |
PEG | -0.00x |
EV multiple | -1.31x |
About
Altamira Therapeutics Ltd. is a biotechnology firm dedicated to pioneering new treatments for critical medical needs that are currently underserved. Its marketed offerings include Bentrio, a non-pharmaceutical nasal spray designed for individual protection against prevalent airborne viruses and allergens. The company is also heavily invested in developing RNA therapeutics specifically for extrahepatic targets.
Similar securities
Based on sector and market capitalization
Report issue